Program of Immunology and Immunotherapy, Cima Universidad de Navarra, Pamplona, Spain.
Navarra Institute for Health Research (IDISNA), Pamplona, Spain.
Oncoimmunology. 2023 Nov 20;12(1):2285106. doi: 10.1080/2162402X.2023.2285106. eCollection 2023.
Our recent research has unveiled the potential of locoregional immunotherapy. Cytokine-armored viral vectors, such as modified vaccinia virus Ankara vector encoding single-chain interleukin-12 (MVA.scIL-12), can target the omentum and elicit a robust tumor-specific immune response, all the while minimizing toxicity.
我们最近的研究揭示了局部免疫治疗的潜力。细胞因子装甲病毒载体,如编码单链白细胞介素 12(MVA.scIL-12)的改良安卡拉牛痘病毒载体,可以靶向大网膜并引发强烈的肿瘤特异性免疫反应,同时最大限度地减少毒性。